BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11884930)

  • 61. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.
    Verchere CB; D'Alessio DA; Prigeon RL; Hull RL; Kahn SE
    Diabetes; 2000 Sep; 49(9):1477-84. PubMed ID: 10969831
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term treatment with atrial natriuretic peptide inhibits ATP production and insulin secretion in rat pancreatic islets.
    You H; Laychock SG
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E435-44. PubMed ID: 20959527
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The direct effects of tacrolimus and cyclosporin A on isolated human islets: A functional, survival and gene expression study.
    Bugliani M; Masini M; Liechti R; Marselli L; Xenarios I; Boggi U; Filipponi F; Masiello P; Marchetti P
    Islets; 2009; 1(2):106-10. PubMed ID: 21099257
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Calcineurin inhibitors and mechanisms that are responsible for the appearance of post-transplant diabetes mellitus].
    Ippoliti GB; Viganò M
    G Ital Nefrol; 2003; 20 Suppl 25():S11-4. PubMed ID: 14523907
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans.
    Poitout V; Rouault C; Guerre-Millo M; Briaud I; Reach G
    Endocrinology; 1998 Mar; 139(3):822-6. PubMed ID: 9492008
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dysfunction of the islet lysosomal system conveys impairment of glucose-induced insulin release in the diabetic GK rat.
    Salehi A; Henningsson R; Mosén H; Ostenson CG; Efendic S; Lundquist I
    Endocrinology; 1999 Jul; 140(7):3045-53. PubMed ID: 10385396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Surface camouflage of pancreatic islets using 6-arm-PEG-catechol in combined therapy with tacrolimus and anti-CD154 monoclonal antibody for xenotransplantation.
    Jeong JH; Hong SW; Hong S; Yook S; Jung Y; Park JB; Khue CD; Im BH; Seo J; Lee H; Ahn CH; Lee DY; Byun Y
    Biomaterials; 2011 Nov; 32(31):7961-70. PubMed ID: 21831422
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phospho-serine/threonine phosphatases in rat islets of Langerhans: identification and effect on insulin secretion.
    Murphy LI; Jones PM
    Mol Cell Endocrinol; 1996 Mar; 117(2):195-202. PubMed ID: 8737380
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Beneficial effect of pretreatment of islets with fibronectin on glucose tolerance after islet transplantation.
    Hamamoto Y; Fujimoto S; Inada A; Takehiro M; Nabe K; Shimono D; Kajikawa M; Fujita J; Yamada Y; Seino Y
    Horm Metab Res; 2003 Aug; 35(8):460-5. PubMed ID: 12953162
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extract isolated from Angelica hirsutiflora with insulin secretagogue activity.
    Leu YL; Chen YW; Yang CY; Huang CF; Lin GH; Tsai KS; Yang RS; Liu SH
    J Ethnopharmacol; 2009 Jun; 123(2):208-12. PubMed ID: 19429364
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation.
    Aktas S; Colak T; Baskin E; Sevmis S; Ozdemir H; Moray G; Karakayali H; Haberal M
    Transplant Proc; 2011 Mar; 43(2):453-7. PubMed ID: 21440732
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oxidized but not acetylated low-density lipoprotein reduces preproinsulin mRNA expression and secretion of insulin from HIT-T15 cells.
    Okajima F; Kurihara M; Ono C; Nakajima Y; Tanimura K; Sugihara H; Tatsuguchi A; Nakagawa K; Miyazawa T; Oikawa S
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):173-80. PubMed ID: 15708365
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition.
    Patanè G; Anello M; Piro S; Vigneri R; Purrello F; Rabuazzo AM
    Diabetes; 2002 Sep; 51(9):2749-56. PubMed ID: 12196468
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation.
    Du CY; Xu EK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nerve growth factor increases insulin secretion and barium current in pancreatic beta-cells.
    Rosenbaum T; Sánchez-Soto MC; Hiriart M
    Diabetes; 2001 Aug; 50(8):1755-62. PubMed ID: 11473035
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.
    Zhou YP; Grill V
    J Clin Endocrinol Metab; 1995 May; 80(5):1584-90. PubMed ID: 7745004
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model.
    Montgomery SP; Mog SR; Xu H; Tadaki DK; Hirshberg B; Berning JD; Leconte J; Harlan DM; Hale D; Kirk AD
    Am J Transplant; 2002 Apr; 2(4):381-5. PubMed ID: 12118862
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up.
    Sheashaa HA; Bakr MA; Fouda MA; El-Dahshan KF; Ismail AM; Sobh MA; Ghoneim MA
    Int Urol Nephrol; 2007; 39(1):317-9. PubMed ID: 17333530
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.
    Novelli M; Pocai A; Lajoix AD; Beffy P; Bezzi D; Marchetti P; Gross R; Masiello P
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):77-82. PubMed ID: 15149729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.